Table 1.
Characteristic | Stricture Group (n = 49) | Nonstricture Group (n = 214) | P Value |
---|---|---|---|
Age, mean, y | 60 | 59 | |
Gender | |||
Male | 78 (38) | 82 (176) | .42 |
Female | 22 (11) | 18 (38) | |
Initial treatment | |||
Radiation | 31 (15) | 29 (61) | .80 |
Chemo/radiation | 22 (11) | 27 (58) | |
Surgery | 47 (23) | 44 (95) | |
Adjuvant therapy | |||
Radiation | 18 (9) | 22 (47) | .39 |
Chemo/radiation | 14 (7) | 10 (22) | |
Initial tumor site | |||
Oropharynx | 0 | 4 (8) | .40 |
Hypopharynx | 27 (13) | 16 (34) | |
Larynx | |||
Supraglottic | 27 (13) | 29 (61) | |
Glottic | 43 (21) | 49 (105) | |
Subglottic | 2 (1) | 1 (2) | |
Other | 2 (1) | 2 (4) | |
T classification | |||
1 | 2 (1) | 2 (5) | .59 |
2 | 4 (2) | 11 (23) | |
3 | 37 (18) | 34 (73) | |
4 | 51 (25) | 49 (105) | |
TMN stage | |||
I | 0 | 2 (4) | .24 |
II | 2 (1) | 7 (15) | |
III | 22 (11) | 19 (41) | |
IV | 71 (35) | 68 (145) | |
Regional metastasis | |||
No positive nodes | 61 (30) | 61 (131) | 1.00 |
Positive nodes | 39 (19) | 39 (83) | |
Distant metastasis | |||
No metastasis | 84 (41) | 85 (182) | .82 |
Positive metastasis | 16 (8) | 15 (32) | |
Follow-up, mo, median (mean) | 18 (26) | 9 (17) | |
Tobacco history | |||
No | 6 (3) | 5 (11) | .73 |
Yes | 86 (42) | 86 (183) | |
Unknown | 8 (4) | 10 (21) | |
Ethanol history | |||
None | 29 (14) | 32 (69) | .04 |
Light | 10 (5) | 11 (24) | |
Moderate | 20 (10) | 11 (24) | |
Heavy | 27 (13) | 19 (41) | |
Unknown | 14 (7) | 27 (57) |
Values presented as No. (%) unless otherwise specified. P <.05 was considered statistically significant (bold) by Fisher exact test or χ2 test.